GPCR FY 2022 Earnings — Structure Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

GPCRStructure Therapeutics Inc.

$3B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$53M

Net Income

-$51M

EPS (Diluted)

$-1.44

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$46M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$98M

Total Liabilities

$213M

Stockholders' Equity

-$115M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$53M	-$38M	-39.4%
Net Income	-$51M	-$40M	-28.3%